A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein

Vaccine

Volumn 15, Issue 5, 1997, Pages 489-496

  Nakamura, Yurie ^a   Kameoka, Masanori ^a   Tobiume, Minoru ^a,b   Kaya, Masumi ^c   Ohki, Kohji ^c   Yamada, Takeshi ^b   Ikuta, Kazuyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c Calpis Food Industry Co Ltd   (Japan)

Author keywords

cytotoxic T lymphocyte; epitope; Gag; human immunodeficiency virus type 1

Indexed keywords

EPITOPE; FREUND ADJUVANT; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LYMPHOCYTE ANTIGEN; SODIUM CHLORIDE; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; B-LYMPHOCYTES; CONSERVED SEQUENCE; EPITOPE MAPPING; HIV CORE PROTEIN P24; MICE; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0030903294     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00224-1     Document Type: Article

References (43)

1. McMichael, A.J., Gotch, F.M., Noble, G.R. and Bears, P.A.S. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 1983, 309, 13-17
2. Moss, D.J., Rickinson, A.B. and Pope, J.H. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of sero-positive donor leukocytes. Int. J. Cancer 1978, 22, 662-668
3. Koup, R.A., Safrit, J.T. and Cao, Y. et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 1994, 68, 4650-4655
4. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994, 370, 463-467
5. Hoffenbach, A., Langlade-Demoyen, P. and Dadaglio, G. et al. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 1989, 142, 452-462
6. Walker, B.D. and Plata, F. Cytotoxic T lymphocytes against HIV. AIDS 1990, 4, 177-184
7. Carmichael, A., Jin, X., Sissons, P. and Borysiewicz, L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-l)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 1993, 177, 249-256
8. Gupta, P., Kingsley, L., Armstrong, J., Ding, M., Cottrill, M. and Rinaldo, C. Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology 1993, 196, 586-595
9. Michael, N.L., Mo, T. and Merzouki, A. et al. Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J. Virol. 1995, 69, 1868-1877
10. Cao, Y., Ho, D.D. and Todd, J. et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res. Hum. Retroviruses 1995, 11, 353-361
11. Klein, M.R., Van Baalen, C.A. and Holwerda, A.M. et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 1995, 181, 1365-1372
12. Rinaldo, C., Huang, X.L., Fan, Z. et al. High levels of antihuman immunodeficiency virus type 1 (HIV-1) memory cyto-toxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 1995, 69, 5838-5842
13. Klein, M.R. and Miedema, F. Long-term survivors of HIV-1 infection. Trends Microbiol. 1995, 3, 386-391
14. McCune, J.M. HIV-1: the infective process in vivo. Cell 1991, 64, 351-363
15. Venet, A. and Walker, B.D. Cytotoxic T-cell epitopes in HIV/SIV infection. AIDS 1993, 7 Suppl., 117-126
16. Javaherian, K., Langlois, A.J. and McDanal, C. et al. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl Acad. Sci. USA 1989, 86, 6768-6772
17. Clerici, M., Lucey, D.R., Zajac, R.A. et al. Detection of cytotoxic T lymphocytes specific for synthetic peptides or gp160 in HIV-seropositive individuals. J. Immunol. 1991, 146, 2214-2219
18. + cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP 120. Virology 1992, 188, 502-509
19. Kameoka, M., Nishino, Y. and Matsuo, K. et al. Cytotoxic T lymphocyte response in mice induced by α recombinant BCG vaccination which produces an extracelluer a antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3-loop. Vaccine 1993, 12, 153-158
20. Casement, K.S., Nehele, P.N., Arlinghaus, R.B. and Sastry, K.J. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1. Virology 1995, 211, 261-267
21. McKnight, A. and Clapham, P.R. Immune escape and tropism of HIV. Trends Microbiol. 1995, 3, 356-361
22. Nixon, D.F., Townsend, A.R.M., Elvin, J.G., Rizza, C.R., Gallwey, J. and McMichael, A.J. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant Vaccinia virus and synthetic peptides. Nature 1988, 336, 484-487
23. Koup, R.A., Sullivan, J.L. and Levine, P.H. et al. Detection of MHC class I restricted HIV specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood 1989, 73, 1909-1914
24. Riviere, Y., Tanneau-Salvadori, F. and Regnault, A. et al. Human immunodeficiency virus-specific cytotoxic responses of sero-positive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J. Virol. 1989, 63, 2270-2277
25. Johnson, R.P., Trocha, A. and Yang, L. et al. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 1991, 147, 1512-1521
26. gag protein. J. Virol. 1993, 67, 694-702
27. Matsuo, K., Nishino, Y. and Kimura, T. et al. Highly conserved epitope domain in major core protein p24 is structurally similar among human, simian and feline immunodeficiency viruses. J. Gen. Virol. 1992, 73, 2445-2450
28. Nishino, Y., Ohki, K., Kimura, T., Morikawa, S., Mikami, T. and Ikuta, K. Major core proteins, p24s, of human, simian, and feline immunodeficiency viruses are partly expressed on the surface of the virus-infected cells. Vaccine 1992, 10, 677-683
29. Truong, C., Brand, D., Mallet, F., Roingeard, P., Brunei, S. and Barin, F. Assembly and immunogenicity of chimeric Gag-Env proteins derived from the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 1996, 12, 291-301
30. Louwagie, J., McCutchan, F.E. and Peeters, M. et al. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993, 7, 769-780
31. Ikuta, K., Morita, C. and Miyake, S. et al. Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens. Virology 1989, 170, 408-417
32. Nishino, Y., Kameoka, M. and Okada, Y. et al. In vivo induction of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes and delayed-type hypersensitivity by a 23-amino acid peptide from the highly conserved region in major core protein p24. Vaccine 1994, 12, 485-491
33. Hinkula, J., Rosen, J., Sundqvist, V.A., Stigbrand, T. and Wahren, B. Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Molec. Immunol. 1990, 27, 395-403
34. b molecule. Nature 1990, 348, 213-216
35. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G. and Rammensee, H.G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351, 290-296
36. Jardetzky, T.S., Lane, W.S., Robinson, R.A., Madden, D.R. and Wiley, D.C. Identification of self peptides bound to purified HLA-B27. Nature 1991, 353, 326-329
37. Hunt, D.F., Henderson, R.A. and Shabanowitz, J. et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992, 255, 1261-1263
38. Rudensky, A.Yu., Preston-Hurlburt, P., Hong, S.C., Barlow, A. and Janeway, C.A.Jr. Sequence analysis of peptides bound to MHC class II molecules. Nature 1991, 353, 622-627
39. Hunt, D.F, Michel, H. and Dickinson, T.A. et al. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 1992, 256, 1817-1820
40. Liu, Z., Williams, K.P., Chang, Y.H. and Smith, J.A. Immunodominance: a single amino acid substitution within an antigenic site alters intramolecular selection of T cell determinants. J. Immunol. 1993, 151, 1852-1858
41. Argos, P. A possible homology between immunodeficiency virus p24 core protein and picornaviral VP2 coat protein: prediction of HIV p24 antigenic sites. EMBO J. 1989, 8, 779-785
42. Coates, A.R.M., Cookson, J., Barton, G.J., Zvelebil, M.J. and Sternberg, M.J.E. AIDS vaccine predictions. Nature 1987, 326, 549-550
43. Schrier, R.D., Gnann, J.W.Jr and Landes, R. et al. T cell recognition of HIV synthetic peptides in a natural infection. J. Immunol. 1989, 142, 1166-1176